A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory Lymphoma

NCT02259010 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Relapsed/Refractory Lymphoma

Interventions

DRUG: Alisertib
DRUG: Itraconazole

Sponsor

Millennium Pharmaceuticals, Inc.